We showed that SCD retains considerable enzymatic activity even in remarkably hypoxic disorders—a result that should motivate SCD inhibitor therapeutics in other stable tumors. In addition to delaying tumor growth, the inhibitor experienced an unexpected helpful effect on tumor vasculature, secondary to its impact on tumor cells. GBM can be https://matthewx110jue3.ageeksblog.com/profile